SCHEMBL9728699

SCHEMBL9728699

CC(C)C(c1ccc(NC(=O)Cc2cccc(Cl)c2)c([N+](=O)[O-])c1)n1ccnc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNQ2 O43526 4/20 0.41
PKM P14618 2/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
MAPK1 P28482 2/20 0.40
MAPT P10636 3/20 0.40
ROCK2 O75116 1/20 0.39
CACNA1G O43497 1/20 0.38
CACNA1H O95180 1/20 0.38
CACNA1C Q13936 1/20 0.38
CACNA1I Q9P0X4 1/20 0.38
ALDH1A1 P00352 2/20 0.38
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
CSNK1D P48730 1/20 0.38
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
ANO1 Q5XXA6 1/20 0.38
POLB P06746 1/20 0.38
CYP1A2 P05177 1/20 0.37
CYP3A4 P08684 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9196029 0.91 L3MBTL1 (0.51) PKML3MBTL1MAPK1MAPTALDH1A1
SCHEMBL9728169 0.90 MAPT (0.41) KCNQ2PKML3MBTL1MAPK1MAPT
SCHEMBL9728757 0.85 PKM (0.41) KCNQ2PKML3MBTL1MAPK1MAPT
SCHEMBL9728217 0.84 CYP17A1 (0.45) PKML3MBTL1MAPTMEN1KMT2A
SCHEMBL9191000 0.81 CYP17A1 (0.44) MAPK1MAPTALDH1A1MEN1KMT2A
SCHEMBL10582410 0.81 MAPT (0.46) PKMMAPTMEN1KMT2APOLB
SCHEMBL9192569 0.79 CYP19A1 (0.46) PKMMAPK1MAPTALDH1A1POLB
SCHEMBL10577494 0.78 CYP17A1 (0.48) PKML3MBTL1MAPK1MAPTALDH1A1
SCHEMBL9728006 0.77 CYP17A1 (0.47) MEN1KMT2ACYP3A4HTTCYP17A1
SCHEMBL9728356 0.75 MAPT (0.49) PKML3MBTL1MAPK1MAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1036003-C A process for preparing (1H-azol-1-ylmethyl) substituted quinoxaline derivatives JANSSEN PHARMACEUTICA NV (BE) 1997-10-01 CN disclosed
CN-1033752-C (1H-azol-1-ylmethyl) substituted quinoline or quinolinone derivatives JANSSEN PHARMACEUTICA NV (SE) 1997-01-08 CN disclosed
CN-1106005-A A process for preparing (1H-azol-1-ylmethyl) substituted quinoxaline derivatives JANSSEN PHARMACEUTICA NV (BE) 1995-08-02 CN disclosed
CN-1106004-A A process for preparing (1H-azol-1-ylmethyl) substituted quinazoline derivatives JANSSEN PHARMACEUTICA NV (BE) 1995-08-02 CN disclosed
US-5151421-A Compounds for inhibition of metabolism of retinoids, for treatment for proliferation of epithelial cells and keratin disorders JANSSEN PHARMACEUTICA N.V. (BE) 1992-09-29 US disclosed
US-5028606-A Retinoid metabolism inhibitors JANSSEN PHARMACEUTICA N.V. (BE) 1991-07-02 US disclosed
CN-1042912-A (1H-oxazol-1-ylmethyl) substituted quinoline, quinazoline or quinoxaline derivatives JANSSEN PHARMACEUTICA NV (BE) 1990-06-13 CN disclosed